Page last updated: 2024-10-27

gentamicin and Bronchopulmonary Dysplasia

gentamicin has been researched along with Bronchopulmonary Dysplasia in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Novitsky, A1
Tuttle, D1
Locke, RG1
Saiman, L1
Mackley, A1
Paul, DA1

Other Studies

1 other study available for gentamicin and Bronchopulmonary Dysplasia

ArticleYear
Prolonged early antibiotic use and bronchopulmonary dysplasia in very low birth weight infants.
    American journal of perinatology, 2015, Volume: 32, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bronchopulmonary Dysplasia; Case-Control Studies; Cohor

2015